Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)

0 保存 · 0 分享 · 0 评论参与讨论

资助机构

National Institutes of Health (NIH)

Department of Health and Human Services (HHS)

地区

United States

研究领域

Health

截止日期

Jul 12, 2023 12:00:00 AM EDT (已过期)

基金规模

$325,000

联系方式

National Institutes of Health OERWebmaster03@od.nih.gov

申请资格

Eligible Applicants:

Small businesses

Additional Information on Eligibility:

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

基金编号

RFA-TR-22-029

说明

The purpose of this Funding Opportunity Announcement (FOA) is to support basket clinical trials of drugs targeting shared molecular etiologies in more than one rare disease. To facilitate clinical trial start up, and leverage existing datasets, preference will be given to applications focusing on diseases that are under study by the Rare Disease Clinical Research Network (RDCRN), and that involve collaborations with RDCRN clinical investigators.

网站

http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-22-029.html

基金资源
Purdue Grant Writing Lab: Introduction to Grant Writing	打开链接
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	打开链接